Interpace Biosciences (IDXG) Reports Q3 EPS of $0.04

Interpace Biosciences (OTC: IDXG) reported Q3 EPS of $0.04. Revenue for the quarter came in at $8.76 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Robinhood Markets (HOOD) PT Raised to $130 at Cantor Fitzgerald
• Rubio to visit Gulf states amid Iran deal concerns